I accumulated shares of GSAC in the .003-.0035 range last week. GSAC acquired ownership of Mastix Medica about two years ago (and in the process gained exposure to the cannabis sector). GSAC is involved in the research/development, formulation, manufacturing, and marketing of over-the-counter healthcare products (gum, tablets, lozenges, mints, candies, etc.). The company has a patent-pending manufacturing process for incorporating hemp-oil into gums and tablets.
Its a very high-risk investment, but the stock looks relatively attractive given its under-followed nature and the current market interest for sub-penny cannabis plays.
Although it is about a year old, the GSAC Executive Summary from November 2015 provides a nice amount of information about the company and its plans it had heading into year 2016. Included in the summary is info on its cannabis-related activity (products, clinical studies, etc.) and some financial/business information regarding potential products in the pipeline.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.